Trading at a discount compared to peers, but the underlying intrinsic cash flows struggle to support the current price.
Moderate quality score of 73/100, reflecting stable operating margins and manageable leverage.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Solid fundamental quality, though profitability presents a headwind.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. However, capital return yields remain modest, driven predominantly by aggressive share repurchases.
Returns capital exclusively via buybacks — no active dividend
BB demonstrates adequate business quality with stable profitability. This is backed by a fortress balance sheet, holding significant net cash ($59M) and minimal debt risk.
The company exhibits steady, low-single-digit revenue growth paired with stable bottom-line earnings. Operating efficiency remains adequate with margins around 11.4%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $152.9M | +4.3% | +2.0% | -9.0% | -12.7% | |
| EBITDA | $19.5M | — | — | — | — | |
| Net Income | $8.5M | +168.4% | — | — | — | |
| EPS (Diluted) | $0.01 | +169.2% | — | — | — | |
| Free Cash Flow | $100K | +638.4% | — | +4.5% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 76.8% | 70.9% | 69.5% | 68.9% |
| Operating Margin | 11.4% | 4.5% | -11.1% | -24.7% |
| Net Margin | 10.3% | -7.4% | -32.0% | -33.7% |
| FCF Margin | 11.1% | 2.2% | -12.1% | -0.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.03 | $0.04 | +33.3% | ||
| Q2'26 | $0.05 | $0.06 | +20.0% | ||
| Q4'25 | $0.04 | $0.05 | +25.9% | ||
| Q3'25 | $0.01 | $0.04 | +300.0% | ||
| Q2'25 | $0.01 | $0.02 | +42.9% | ||
| Q2'25 | $0.02 | $0.03 | +50.0% | ||
| Q4'24 | $-0.01 | $0.02 | +300.0% | ||
| Q3'24 | $-0.01 | $-0.01 | -100.0% |
Total return is +157.5% (1Y), outperforming the benchmark by +78.2%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +192.1% | +119.5% | — |
| 1Y | +157.5% | +78.2% | — |
| 3YCAGR | +21.7% | +3.2% | — |
| 5YCAGR | -7.4% | -19.2% | — |
| 10YCAGR | +2.6% | -11.4% | — |
The S&P 500 is at 31.4x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about BlackBerry Limited (BB) valuation, health, and returns.
BlackBerry Limited is estimated to be overvalued under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. overvalued (implying -33.7% downside from DCF intrinsic value of $7.63)
BlackBerry Limited has multiple valuation anchors: DCF Intrinsic Value: $7.63 | Peer Relative Fair Value: $26.90 | Wall Street Analyst Target: $10.54 (implying -5.0% upside). A convergence of these signals offers higher conviction.
BlackBerry Limited displays good financial health with a composite quality score of 73/100, supported by a Altman Z-Score of 6.1 (safe zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 7.3%.
BlackBerry Limited returns capital via buybacks instead of dividends, carrying a 0.9% buyback yield and reducing outstanding shares by +1.0% in the last 12 months.
BlackBerry Limited's current growth trajectory is Accelerating. The company achieved +4.3% 1Y revenue growth and +169.2% 1Y EPS growth, compared to its 3Y revenue CAGR of +2.0%.
Wall Street consensus is Hold based on 14 analysts, beating EPS expectations in 75% of recent quarters with a 7-quarter streak. The consensus price target represents a -5.0% change from current levels.
Investment risks for BlackBerry Limited include: -37.0% 1-year max drawdown, high beta (1.53x market volatility). Volatility risk is characterized by a beta of 1.53x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.